Kauris-CTS 750 Injection
Images are for reference. Actual packaging may vary.
Ceftriaxone (500mg) + Sulbactam (250mg)
Vial of 1 injection • Injection
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Ceftriaxone binds to penicillin-binding proteins, inhibiting cell wall synthesis and leading to bacterial lysis.
Sulbactam irreversibly binds to beta-lactamase enzymes, preventing them from inactivating beta-lactam antibiotics.
Medical applications
Kauris-CTS 750 Injection is a sterile, injectable antibiotic formulation containing Ceftriaxone 500 mg and Sulbactam 250 mg. Ceftriaxone, a third-generation cephalosporin, exhibits broad-spectrum bactericidal activity by inhibiting bacterial cell wall synthesis, effective against a wide range of Gram-positive and Gram-negative pathogens. Sulbactam, a beta-lactamase inhibitor, enhances the efficacy of Ceftriaxone by preventing enzymatic degradation of the antibiotic, thereby extending its spectrum to beta-lactamase producing resistant strains.
This combination is indicated for the treatment of moderate to severe infections including lower respiratory tract infections, complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and septicemia caused by susceptible organisms. Kauris-CTS 750 Injection is administered via intramuscular or intravenous routes, with dosage and duration tailored according to the severity of infection and patient-specific factors such as renal function.
It is contraindicated in patients with known hypersensitivity to cephalosporins or beta-lactam antibiotics. Common adverse reactions may include local injection site pain, rash, gastrointestinal disturbances, and transient elevation of liver enzymes. Caution is advised in patients with a history of penicillin allergy. Proper reconstitution and aseptic technique are essential to ensure safety and therapeutic efficacy.
How to use Kauris-CTS Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Consuming alcohol with Kauris-CTS 750 Injection does not cause any harmful side effects.
High Risk
Kauris-CTS 750 Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Kauris-CTS 750 Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Kauris-CTS 750 Injection should be used with caution in patients with severe liver disease. Dose adjustment of Kauris-CTS 750 Injection may be needed. Please consult your doctor. Dose adjustment of Kauris-CTS 750 Injection is not recommended in patients with mild to moderate liver disease.
Regular Checkup
Kauris-CTS 750 Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Consult Doctor
There is limited information available on the use of Kauris-CTS 750 Injection in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Kauris-CTS 750 Injection







